Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?

INTRODUCTION The American Association for the Study of Liver Diseases recommends hepatitis D virus (HDV) screening in certain high-risk groups; however, the effectiveness is unknown. METHODS A study of North American patients with hepatitis B (HBV) referred to the NIH was performed to identify risk factors associated with HDV infection. Active HDV was "confirmed" by serum HDV RNA or histologic HDV antigen staining. RESULTS Six hundred fifty-two were studied, of which 91 were HDV "confirmed." Independent risk factors for HDV included: intravenous drug users, HBV-DNA <2,000 IU/mL, alanine aminotransferase >40 U/L, and HDV endemic country of origin. DISUSSION North American patients with HBV and significant risk factors should be screened for HDV.

[1]  S. Hadler,et al.  Hepatitis D Virus Infection in Illinois State Facilities for the Developmental Disabled , 2020 .

[2]  H. Goyal,et al.  Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis , 2018, Gut.

[3]  B. McMahon,et al.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance , 2018, Hepatology.

[4]  H. Günthard,et al.  Hepatitis delta-associated mortality in HIV/HBV-coinfected patients. , 2017, Journal of hepatology.

[5]  M. Serper,et al.  Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes. , 2015, Journal of hepatology.

[6]  G. Touloumi,et al.  Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study. , 2013, Journal of hepatology.

[7]  M. Winters,et al.  Coinfection with hepatitis B and D: Epidemiology, prevalence and disease in patients in Northern California , 2013, Journal of gastroenterology and hepatology.

[8]  L. Kucirka,et al.  Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. , 2010, The Journal of infectious diseases.

[9]  W. Sheng,et al.  Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. , 1995, Gastroenterology.

[10]  M. Kreek,et al.  Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. , 1988, The Journal of infectious diseases.

[11]  I. Mushahwar,et al.  Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus. , 1985, American journal of epidemiology.

[12]  R. Purcell,et al.  Hepatitis B Markers in United States Drug Addicts with Special Emphasis on the Delta Hepatitis Virus , 1984, Hepatology.

[13]  C. Sureau The role of the HBV envelope proteins in the HDV replication cycle. , 2006, Current topics in microbiology and immunology.